# Mirtazapine for Sleep Disorders in Alzheimer's Disease

> **NCT01867775** · PHASE3 · UNKNOWN · sponsor: **Brasilia University Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Alzheimer's Disease
- Sleep Disorders

## Interventions

- **DRUG:** Mirtazapine

## Key facts

- **NCT ID:** NCT01867775
- **Lead sponsor:** Brasilia University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2013-12
- **Final completion:** 2014-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01867775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01867775, "Mirtazapine for Sleep Disorders in Alzheimer's Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01867775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*